1-1 of 1
Scott Cruickshank, BA, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Carfilzomib (CFZ), a Novel Proteasome Inhibitor for Relapsed or Refractory Multiple Myeloma, Is Associated with Minimal Peripheral Neuropathic Effects.

Ravi Vij, MD, Luhua Wang, MD, Robert Z Orlowski, M.D., Ph.D., A. Keith Stewart, MD, Sundar Jagannath, MD, Sagar Lonial, MD, Suzanne Trudel, MD, Andrzej J Jakubowiak, MD, PhD, Andrew Belch, MD, Melissa Alsina, MD, Nizar J Bahlis, MD, Mai H. Le, MD, Scott Cruickshank, BA, MS, Mark K Bennett, PhD, Susan Molineaux, PhD, Michael Kauffman, MD, PhD, David Siegel, MD, The Multiple Myeloma Research Consortium (MMRC)
Journal: Blood
Blood (2009) 114 (22): 430.
https://doi.org/10.1182/blood.V114.22.430.430
Published: 2009